Status:
COMPLETED
Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
65+ years
Phase:
PHASE3
Brief Summary
Atrial fibrillation (AF) is the most common arrhythmia and a common cause of stroke. AF can be asymptomatic and remain undiagnosed. Both the prevalence of AF and the proportion of strokes related to u...
Detailed Description
In a recent validation study performed in 200 patients visiting a cardiology outpatient clinic, the sensitivity was 100%, and specificity 96.4% with the MyDiagnostics as compared to a 12-lead ECG. Ade...
Eligibility Criteria
Inclusion
- Community dwelling persons visit the GP and aged 65 years of over
Exclusion
- Terminal illness of such severity that anticoagulation is considered to be not appropriate in case of newly detected atrial fibrillation
- Acute situation in which GP should act instantly
- Patients with a history of AF
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2016
Estimated Enrollment :
16000 Patients enrolled
Trial Details
Trial ID
NCT02270151
Start Date
November 1 2014
End Date
February 1 2016
Last Update
May 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GP practices
Utrecht, Utrecht, Netherlands